Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?
The DOI matches its Crossref record.
Abstract
Article Abstract Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text. To the Editor: A recent review on oral ketamine for depression described an antidepressant effect that was delayed in the range of 2-6 weeks, as compared to the rapid action of intravenous (IV) ketamine treatment. This differs from our clinical experience using sublingual (SL) ketamine to treat patients with severely treatment-resistant depression (TRD). In our experience, SL ketamine can both provide and sustain rapid antidepressant effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies on oral and sublingual ketamine have been the subject of a recent systematic review,67 but the studies reviewed include wide variations in dosing and do not appear to take into account limited bioavailability of oral formulations, so may underestimate efficacy.68”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [68]
Citations
Cites
Still being checked.
Cited by
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Self-citationThe molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
Hull, T. D., Malgaroli, M., Gazzaley, A., Akiki, T. J., Madan, A., Vando, L., Arden, K., Swain, J., Klotz, M., & Paleos, C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.004 · Cited by 58
Swainson, J., Klassen, L. J., Brennan, S., Chokka, P. R., Katzman, M. A., Tanguay, R. L., & Khullar, A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00897-2 · Cited by 53
Self-citationMathai, D. S., Hull, T. D., Vando, L., & Malgaroli, M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.131 · Cited by 28
Metadata
- Authors
- Swainson, J., & Khullar, A.
- Affiliations
- University of Alberta (CA)
- ORCID
- Swainson, Jennifer
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2020-01-28
- Volume
- 81
- Issue
- 1
- ISSN
- 0160-6689 (ISSN-L)
- 1555-2101
- OpenAlex
- W3003780086
- Cited by
- 9
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- ketamine, treatment-resistant depression, rapid antidepressant response, oral ketamine, intravenous ketamine
- MeSH terms
- Anesthetics, Dissociative, Antidepressive Agents, Biological Availability, Dose-Response Relationship, Drug, Drug Administration Routes, Humans, Ketamine, Risk Assessment, Patient Selection, Substance-Related Disorders, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression? https://app.cochat.ai/papers/10.4088/jcp.19lr13146
- The paper
- Swainson, J., & Khullar, A. (2020). Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression? The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.19lr13146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.